Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACs.
Actis M, Cresser-Brown J, Caine EA, Steger M, Aggarwal A, Mayasundari A, Murphy N, Valinciute G, Li Y, Fu X, Yang L, Marsh G, Hughes G, Karadogan B, Wheeler D, Norley M, Spain F, Urh M, Roussel MF, Schwalb B, Daub H, Riching KM, Maple H, Nishiguchi G, Rankovic Z.
Actis M, et al. Among authors: li y.
J Med Chem. 2025 Jan 15. doi: 10.1021/acs.jmedchem.4c02709. Online ahead of print.
J Med Chem. 2025.
PMID: 39813384